% | $
Quotes you view appear here for quick access.

VPHM Message Board

  • nuhawkus nuhawkus Oct 31, 2002 12:34 PM Flag


    VPHM's FAQ contains the following: *currently are discussing with the FDA the data from these studies. FDA recently has raised certain issues related to the formulation being used to administer VP14637* This seems to indicate that the FDA's concern is with the delivery system rather than the RSV compound. Did the conference call offer any further info on just what the hangup is?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Nah, just a brief comment with the same sort of nebulous BS. I suspect that they're just stalling until a backup with better bioavailability is ready??

      But the conference call replay is worth listening to. Innuendo at the end.... sounds like they're finally moving on the bioterror or West Nile fronts, or both.